Trulieve investor presentation highlighted NYSE listing under ticker TRLV, following medical marijuana rescheduling to Schedule III.
Corporate restructuring deconsolidated Harvest mixed-use operations to support the NYSE listing; Trulieve retained 90% economic interest.
Consolidated business positioned as DEA-registered, state-licensed medical-only operations with 207 dispensaries and 3.5 million sq. ft. capacity.
Harvest platform described as independently controlled, spanning Arizona, Connecticut, Maryland, Ohio with 34 dispensaries and 0.5 million sq. ft. capacity.
TRLV•
